Published in Blut on May 01, 1985
Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol (2001) 7.30
Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development (1994) 3.71
Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med (2000) 2.94
Two genetically separable steps in the differentiation of thymic epithelium. Science (1996) 2.66
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood (1988) 1.69
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol (2004) 1.62
Selection of a broad repertoire of CD4+ T cells in H-2Ma0/0 mice. Immunity (1997) 1.32
Sampling of complementing self-antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance. Eur J Immunol (2001) 1.32
Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood (1996) 1.26
Self-antigen presentation by thymic stromal cells: a subtle division of labor. Curr Opin Immunol (2000) 1.21
CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med (1998) 1.19
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia. Ann Hematol (2004) 1.15
A filarial cysteine protease inhibitor down-regulates T cell proliferation and enhances interleukin-10 production. Eur J Immunol (1997) 1.13
"Promiscuous" expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity? J Mol Med (Berl) (2000) 1.01
Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen-presenting cells. Eur J Immunol (1993) 1.01
Presentation and intercellular transfer of self antigen within the thymic microenvironment: expression of the E alpha peptide-I-Ab complex by isolated thymic stromal cells. Int Immunol (1994) 0.99
Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med (1991) 0.99
Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients. Ann Hematol (1996) 0.98
Composition of the lymphoid cell populations from omental milky spots during the immune response in C57BL/Ka mice. Eur J Immunol (1986) 0.94
CD4+ helper T cells are required for resistance to a highly metastatic murine tumor. Eur J Immunol (1987) 0.93
Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML. Br J Haematol (1998) 0.93
Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood (1991) 0.92
Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation. Ann Hematol (1998) 0.90
Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia (1989) 0.89
The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group. Leukemia (1992) 0.89
Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12. Br J Haematol (1998) 0.88
Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia. Leukemia (2004) 0.86
Transcription factors that control development of the thymic microenvironment. Immunol Today (1995) 0.86
Identical forms of the CD2 antigen expressed by mouse T and B lymphocytes. Eur J Immunol (1989) 0.85
GcvR interacts with GcvA to inhibit activation of the Escherichia coli glycine cleavage operon. Microbiology (2001) 0.85
Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood (1995) 0.85
Tolerance and immunity to the inducible self antigen C-reactive protein in transgenic mice. Eur J Immunol (1995) 0.85
Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial. Bone Marrow Transplant (1998) 0.82
Interleukin-2 bolus infusion as late consolidation therapy in 2nd remission of acute myeloblastic leukemia. Leuk Lymphoma (1995) 0.81
The German competence network 'Acute and chronic leukemias'. Leukemia (2004) 0.81
Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand. Eur J Immunol (1995) 0.81
Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period. Ann Hematol (1994) 0.81
Use of bioassay methods to evaluate mutagenicity of ambient air collected near a municipal waste combustor. JAPCA (1989) 0.80
Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia. Chemotherapy (1998) 0.80
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant (2001) 0.80
[Problems in the diagnosis of Addison's disease in the absence of hyperpigmentation]. Z Gesamte Inn Med (1981) 0.80
Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia. Leukemia (2000) 0.80
Central venous catheter infections in patients with acute leukemia. Chemotherapy (2002) 0.79
Receptor-mediated endocytosis of CD34 on hematopoietic cells after stimulation with the monoclonal antibody anti-HPCA-1. J Hematother Stem Cell Res (2001) 0.79
[The occurrence of Clostridium difficile in fecal samples of dogs and cats]. Zentralbl Veterinarmed B (1989) 0.79
Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics. Leukemia (1998) 0.78
Inhibition of granulocyte-macrophage colony-stimulating factor receptor function by a splice variant of the common beta-receptor subunit. Blood (2001) 0.78
Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. Blood (1988) 0.78
Acute undifferentiated leukemia: implications for cellular origin and clonality suggested by analysis of surface markers and immunoglobulin gene rearrangement. Blood (1986) 0.78
Intensive intravenous amphotericin B for prophylaxis of systemic fungal infections. Results of a prospective controlled pilot study in acute leukemia patients. Chemotherapy (2000) 0.78
Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes. Eur J Biochem (2001) 0.78
Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia. Leukemia (2011) 0.78
Increase of T lymphocyte self-reactivity in aging inbred rats: in vitro studies with a model of experimental autoimmune orchitis. J Immunol (1978) 0.78
Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients. Br J Haematol (1999) 0.77
Genetic resistance to Leukosis virus infection: effects on mortality and egg production in Leghorn hens. Br Poult Sci (1984) 0.77
Thymic nurse cells: intraepithelial thymocyte sojourn and its possible relevance for the pathogenesis of AKR lymphomas. Haematol Blood Transfus (1981) 0.77
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML). Ann Hematol (2000) 0.77
Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group. Leukemia (1993) 0.77
Treatment of relapsed acute lymphocytic leukemia in adults. Haematol Blood Transfus (1990) 0.76
Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture. Ann Hematol (1995) 0.76
Effect of stimulation by interferon gamma and tumor necrosis factor alpha on CD54 expression and homotypic aggregation of blasts of acute lymphoblastic leukemias. Ann Hematol (1998) 0.75
[Acute lymphatic leukemia of the adult. Diagnosis, risk groups and therapy]. Internist (Berl) (1996) 0.75
Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. A pilot study. Ann Hematol (1993) 0.75
Leukemic cells on melamine substrate foils. In Vitro Cell Dev Biol (1991) 0.75
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). Leukemia (1990) 0.75
In vitro differentiation of a null-acute leukemia: T-lymphoid surface antigen expression associated with rearrangement in T-cell receptor beta chain variable genes. Cancer Genet Cytogenet (1987) 0.75
[Intensive combined therapy for high-risk ALL patients]. Onkologie (1988) 0.75
Allogenic bone marrow transplantation or chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approach. Ann Hematol (1996) 0.75
Aggressive polychemotherapy for acute myelofibrosis. Eur J Haematol (1990) 0.75
[Domestic animals as excreters of Clostridium difficile]. Dtsch Med Wochenschr (1988) 0.75
[Pseudomonas aeruginosa infections in turkey poults and treatment trials with apramycin]. Berl Munch Tierarztl Wochenschr (1987) 0.75
[Intravital diagnosis of left-atrial tumors--a clinical problem]. Z Gesamte Inn Med (1982) 0.75
Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma. Z Gastroenterol (1999) 0.75
Hepatic lesions of chronic disseminated systemic candidiasis in leukemia patients may become visible during neutropenia: value of serial ultrasound examinations. Blood (1998) 0.75
Detection of chronic systemic candida infection in leukaemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation. Eur J Haematol (1998) 0.75
Fluorescence in situ hybridization and surface markers of fine needle aspiration specimen confirm extramedullary myeloblastoma in a patient with chronic myeloid leukemia. Acta Haematol (1998) 0.75
Human acute unclassified leukemia with a unique t(4;17) chromosomal translocation expresses T lymphoid and myeloid surface antigens after in vitro culture. Blood (1987) 0.75
Deficient IFN alpha production in hairy cell leukemia. Blut (1986) 0.75
[Induction and intensive combined therapy of acute myeloid leukemia in adults]. Onkologie (1988) 0.75
Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage. Haematol Blood Transfus (1990) 0.75
Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia--initial results. Ann Hematol (1993) 0.75
Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia. Semin Oncol (1987) 0.75
TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen. Onkologie (1986) 0.75
[High-dose cytosine arabinoside in the treatment of recurrent or acute refractory myeloid leukemias]. Onkologie (1985) 0.75
Consolidation therapy with high-dose cytosine arabinoside: experiences of a prospective study in acute myeloid leukemia. Haematol Blood Transfus (1990) 0.75
Induction of early myeloperoxidase in acute unclassified leukemia. Haematol Blood Transfus (1987) 0.75
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Blut (1988) 0.75
[Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration]. Wien Med Wochenschr (1998) 0.75
[Indomethacin in the treatment of ureteral colic caused by calculi]. Z Urol Nephrol (1986) 0.75
Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia. Haematol Blood Transfus (1990) 0.75
Age adapted induction and intensified consolidation therapy in acute myelogenous leukemia. Onkologie (1986) 0.75
Conversion of acute undifferentiated leukemia phenotypes: analysis of clonal development. Leuk Res (1986) 0.75
Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood (1988) 0.75
Use of hematopoietic growth factors in the treatment of acute myelogenous leukemia. Curr Opin Hematol (1997) 0.75
Pharmacology of a halogenated aralkylamine with anorectic properties. Arch Int Pharmacodyn Ther (1972) 0.75
[The problem of sequential cancers after antineoplastic chemotherapy or radiotherapy]. Z Gesamte Inn Med (1982) 0.75
Treatment of relapsed or refractory adult acute lymphocytic leukemia. Cancer (1992) 0.75